Business

Botox Maker Sees Early Boost from GLP-1 Trend

Updated 2026-07-23 10:40 UTC 1 source Positive

Galderma, the Botox maker, anticipates an early boost in demand for treatments addressing facial volume loss due to increased use of GLP-1 drugs. The company hopes this trend will fuel growth in its aesthetic products.

Coverage timeline — 1 article

CNBC

Botox maker Galderma sees early boost from 'Ozempic face' trend as GLP-1 use climbs, CEO says

The aestetics company hope increased GLP-1 use will fuel demand for treatments addressing facial volume loss, sometimes dubbed "Ozempic face."

2026-07-23 10:27 UTC